Breast Surgery Practice Questions

Q: A 14-week postpartum woman presents with a fluctuant breast swelling. What is the most appropriate initial treatment?

Repeated aspirations under antibiotic cover. **Explanation:** The clinical presentation of a fluctuant breast swelling in a postpartum woman is diagnostic of a **Lactational Breast Abscess**. **1. Why Option D is Correct:** The current gold standard for the management of lactational breast abscesses is **repeated needle aspiration** (often ultrasound-guided) combined with appropriate **antibiotics** (usually targeting *Staphylococcus aureus*). This approach is preferred over surgical drainage because it results in less scarring, does not require general anesthesia, avoids the risk of a milk fistula, and allows the mother to continue breastfeeding comfortably. **2. Why Other Options are Incorrect:** * **Option A (Incision and Drainage):** While traditionally the treatment of choice, it is now reserved for cases where needle aspiration fails, the skin is thinned/necrotic, or the abscess is very large (>5 cm). It carries a higher risk of milk fistula and prolonged healing. * **Option B (Continue breastfeeding with antibiotics):** This is the treatment for **Mastitis** (cellulitis of the breast). Once a fluctuant mass (abscess) has formed, antibiotics alone are insufficient; the pus must be evacuated. * **Option C (Analgesics):** These are supportive measures but do not treat the underlying infection or the collection of pus. **Clinical Pearls for NEET-PG:** * **Most common organism:** *Staphylococcus aureus*. * **Breastfeeding:** Should **always be continued** from the affected breast (unless there is purulent discharge from the nipple) to prevent milk stasis, which worsens the condition. * **Antibiotic of choice:** Flucloxacillin or Dicloxacillin (Erythromycin if penicillin-allergic). * **Investigation of choice:** Ultrasound is the best modality to differentiate between mastitis and a formed abscess.

Q: Which of the following is true for triple-negative breast cancer?

Aggressive tumor. **Explanation:** Triple-negative breast cancer (TNBC) is defined by the lack of expression of **Estrogen Receptor (ER)**, **Progesterone Receptor (PR)**, and **HER2/neu** amplification. **Why Option A is correct:** TNBC is characterized by an **aggressive clinical course**. It typically presents in younger women, has a higher histological grade, and exhibits a higher rate of visceral metastasis (especially to the brain and lungs) compared to hormone-positive subtypes. It also shows a "peak" in recurrence risk within the first 3–5 years after diagnosis. **Why the other options are incorrect:** * **Option B:** While TNBC is negative for ER and PR, the definition *must* also include negativity for **HER2/neu**. Option B is incomplete as it ignores the HER2 status. * **Option C:** Although TNBC often shows a good initial response to chemotherapy (the "Triple Negative Paradox"), the overall prognosis is **poor** due to high relapse rates and the lack of targeted maintenance therapies. * **Option D:** Tamoxifen is a **Selective Estrogen Receptor Modulator (SERM)**, which is a form of hormonal therapy, not a cytotoxic chemotherapeutic agent. Furthermore, it is ineffective in TNBC because the tumor lacks estrogen receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Genetic Association:** Strongly associated with **BRCA1 mutations**. * **Morphology:** Often presents as a "medullary-like" pattern on histology. * **Investigation of Choice:** IHC (Immunohistochemistry) is used to confirm the triple-negative status. * **Treatment:** Surgery followed by platinum-based chemotherapy is the mainstay; targeted therapies like PARP inhibitors (Olaparib) are used in BRCA-positive cases.

Q: What is true about a modified radical mastectomy?

Pectoralis minor is divided. **Explanation:** Modified Radical Mastectomy (MRM) is the current standard surgical procedure for operable breast cancer. It involves the removal of the entire breast tissue (including the nipple-areola complex and fascia of the pectoralis major) along with an axillary lymph node dissection. **Why Option C is Correct:** In the **Auchincloss modification** of MRM, the pectoralis minor is retracted. However, in the **Patey modification**, the **pectoralis minor is either divided or removed** to facilitate complete access to the Level III (apical) axillary lymph nodes. This allows for a thorough clearance of the axilla while still preserving the pectoralis major muscle. **Analysis of Incorrect Options:** * **A. Pectoralis major is removed:** This is a feature of the **Halsted Radical Mastectomy**, not MRM. In MRM, the pectoralis major is strictly preserved, which leads to better cosmetic and functional outcomes. * **B. Axillary lymph nodes are preserved:** This is incorrect. MRM by definition includes the clearance of Level I, II, and sometimes Level III axillary lymph nodes. Preservation occurs in Simple (Total) Mastectomy. * **D. Internal mammary lymph nodes are removed:** These are removed in an **Extended Radical Mastectomy** (Urban’s procedure), which is rarely performed today due to high morbidity and lack of survival benefit. **NEET-PG High-Yield Pearls:** * **Patey’s MRM:** Removes Pectoralis minor + Level I, II, III nodes. * **Auchincloss MRM:** Preserves Pectoralis minor + removes Level I, II nodes. * **Nerves at risk during MRM:** Long thoracic nerve (Serratus anterior - Winging of scapula), Thoracodorsal nerve (Latissimus dorsi), and Intercostobrachial nerve (most commonly injured; causes numbness of the inner arm).

Q: In a patient with Ca Breast, ipsilateral supraclavicular lymph nodes are positive. Which of the following represents the stage of malignancy in this patient?

Stage III C. ### Explanation The staging of Breast Cancer follows the **AJCC TNM Classification (8th Edition)**. The involvement of **ipsilateral supraclavicular lymph nodes** is a critical anatomical landmark in determining the N-stage and overall clinical stage. #### Why Stage III C is Correct? According to the TNM staging system: * **N3a:** Metastasis in ipsilateral infraclavicular lymph node(s). * **N3b:** Metastasis in ipsilateral internal mammary and axillary lymph nodes. * **N3c:** Metastasis in **ipsilateral supraclavicular lymph node(s)**. Any T (Tumor size) combined with **N3** nodal status automatically categorizes the malignancy as **Stage III C**. This represents advanced regional spread but is still considered "locoregionally advanced" rather than distant metastasis. #### Why Other Options are Incorrect: * **Stage II:** Represents smaller tumors (T1-T2) with limited mobile axillary nodes (N0-N1). Supraclavicular involvement is far too advanced for this stage. * **Stage III B:** This stage is defined by **T4 status** (tumor of any size with direct extension to the chest wall or skin, including inflammatory breast cancer) with N0-N2 nodes. It does not include N3 nodal involvement. * **Stage IV:** This represents **distant metastasis (M1)**. While supraclavicular nodes were once considered M1, they are now classified as **N3 (Stage III C)**. Only contralateral supraclavicular nodes or nodes beyond the regional basin (e.g., cervical, lungs, liver) would signify Stage IV. #### High-Yield Clinical Pearls for NEET-PG: * **N1:** Mobile ipsilateral level I, II axillary nodes. * **N2:** Fixed/matted ipsilateral axillary nodes or clinically detected internal mammary nodes. * **N3:** Infraclavicular, Supraclavicular, or both Internal Mammary + Axillary nodes. * **Prognostic Significance:** Stage III C is the most advanced stage of non-metastatic breast cancer. Treatment usually begins with Neoadjuvant Chemotherapy (NACT).

Q: A 56-year-old male patient develops an eccentric hard breast lump over the past few months. A biopsy proves this to be breast carcinoma. What is the approximate incidence of breast cancer in males as a percentage of all breast cancers?

Less than 1%. **Explanation:** **1. Why the Correct Answer is Right:** Male breast cancer (MBC) is a rare clinical entity. Epidemiological data consistently shows that it accounts for **less than 1%** of all breast cancer cases worldwide and approximately 0.1% of all cancer deaths in men. The low incidence is primarily due to the lack of acini and lobules in the normal male breast, which consists mainly of rudimentary ducts. The most common histological subtype in males is **Invasive Ductal Carcinoma (IDC)**, as lobular carcinoma is extremely rare due to the absence of lobules. **2. Why the Incorrect Options are Wrong:** * **B (4%), C (7%), and D (10%):** These percentages significantly overestimate the prevalence. While the incidence of breast cancer in women is high (1 in 8 lifetime risk), the male-to-female ratio remains approximately **1:100**. Choosing these higher values would imply that male breast cancer is a common clinical encounter, which contradicts global oncological statistics. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Risk Factors:** The strongest risk factor for MBC is **BRCA2 mutation** (more common than BRCA1 in males). Other factors include Klinefelter syndrome (highest relative risk), radiation exposure, and hyperestrogenism (e.g., liver cirrhosis, obesity). * **Clinical Presentation:** Typically presents as a **painless, firm, eccentric subareolar lump**. Because of the lack of breast tissue, skin involvement and nipple retraction occur earlier than in females. * **Diagnosis:** Triple assessment (Clinical, Imaging, Core Biopsy) is standard. Mammography in men has high sensitivity. * **Management:** Modified Radical Mastectomy (MRM) is the traditional surgical treatment of choice. Tamoxifen is the mainstay of hormonal therapy, as ~90% of male breast cancers are ER-positive.

Q: What is considered the gold standard flap for breast reconstruction?

DIEP flap. **Explanation:** The **DIEP (Deep Inferior Epigastric Perforator) flap** is currently considered the **gold standard** for autologous breast reconstruction. The underlying medical concept is the preservation of the rectus abdominis muscle. Unlike the TRAM flap, the DIEP flap involves harvesting only skin and fat (angiosome of the deep inferior epigastric artery) while meticulously dissecting the perforators through the muscle. This results in significantly less donor-site morbidity, a lower risk of abdominal wall hernias, and faster recovery. **Analysis of Incorrect Options:** * **TRAM (Transverse Rectus Abdominis Myocutaneous) flap:** Formerly the gold standard, it involves harvesting a portion of the rectus muscle. This leads to increased donor-site weakness and higher rates of postoperative bulge or hernia. * **LD (Latissimus Dorsi) flap:** This is a reliable musculocutaneous flap but often provides insufficient volume for a full breast, frequently requiring a supplementary implant. It also results in a scar on the back and potential shoulder weakness. * **Silicone gel implant:** This is a prosthetic reconstruction, not a flap. While common, it carries risks of capsular contracture, rupture, and lacks the natural feel and longevity of autologous tissue. **Clinical Pearls for NEET-PG:** * **Vascular Basis:** The DIEP flap is based on the **Deep Inferior Epigastric Artery**. * **Free vs. Pedicled:** DIEP is always a **free flap** requiring microsurgical anastomosis (usually to internal mammary vessels). * **Hartrampf Zones:** Knowledge of abdominal wall perfusion zones (I-IV) is critical for TRAM/DIEP flap planning. * **SIEA Flap:** If the Superficial Inferior Epigastric Artery is used, it is called an SIEA flap, which avoids muscle incision entirely but has inconsistent vascular anatomy.

Q: What is the most malignant type of carcinoma of the breast?

Mastitis carcinomatosa. **Explanation:** **Mastitis carcinomatosa**, also known as **Inflammatory Breast Cancer (IBC)**, is the most aggressive and malignant form of breast cancer. It is characterized by rapid clinical onset, where the breast appears red, swollen, and warm, mimicking an infection (mastitis). The underlying pathology involves the widespread blockage of **dermal lymphatics** by tumor emboli, rather than true inflammation. It is classified as T4d in the TNM staging system and is considered systemic at the time of diagnosis, carrying the poorest prognosis among all breast malignancies. **Analysis of Incorrect Options:** * **Paget’s Disease:** This is a superficial manifestation of an underlying ductal carcinoma (usually DCIS or invasive ductal carcinoma). While it indicates malignancy, it is localized to the nipple-areola complex and is not inherently the "most malignant" form. * **Anaplastic Carcinoma:** While these tumors show high-grade cytological features and poor differentiation, they do not typically exhibit the rapid, diffuse lymphatic spread and dismal survival rates characteristic of inflammatory breast cancer. * **Scirrhous Carcinoma:** This is an older term for Invasive Carcinoma of No Special Type (NST) with significant desmoplasia (fibrosis). It is the most common type of breast cancer but is less aggressive than the inflammatory variant. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Hallmark:** *Peau d'orange* (orange peel appearance) due to cutaneous edema from lymphatic obstruction. * **Diagnosis:** Requires a full-thickness **punch biopsy** of the skin to demonstrate tumor emboli in dermal lymphatics. * **Management:** It is never treated with primary surgery. The standard of care is **Neoadjuvant Chemotherapy (NACT)** followed by Modified Radical Mastectomy (MRM) and Radiotherapy.

Q: Which of the following factors is not included in the TNM staging of carcinoma breast?

Nipple retraction. In the AJCC TNM staging system for breast cancer, staging is determined by the anatomical extent of the disease. The correct answer is **Nipple Retraction** because it is considered a sign of underlying tumor tethering to the ducts rather than an indicator of advanced local invasion (T4 disease). ### **Explanation of Options:** * **Nipple Retraction (Correct):** This is a clinical finding often caused by tumor infiltration of the lactiferous ducts leading to fibrosis. Unlike skin involvement, it does **not** change the T-stage of the tumor. * **Satellite Nodules (Incorrect):** These are defined as separate tumor nodules in the skin ipsilateral to the primary breast tumor. They are classified as **T4b**. * **Inflammation (Incorrect):** Inflammatory breast cancer is a clinical diagnosis characterized by edema (peau d'orange), erythema, and warmth. It is classified as **T4d**. * **Skin Ulceration (Incorrect):** Direct ulceration of the skin by the tumor is a sign of advanced local disease and is classified as **T4b**. ### **High-Yield Clinical Pearls for NEET-PG:** * **T4 Category Breakdown:** * **T4a:** Extension to the chest wall (ribs, intercostals, serratus anterior; *pectoralis muscle involvement alone does not count*). * **T4b:** Edema (peau d'orange), ulceration, or satellite skin nodules. * **T4c:** Both T4a and T4b. * **T4d:** Inflammatory carcinoma. * **Dimpling vs. Retraction:** Skin dimpling or nipple retraction are localized findings and do not upgrade a T1/T2/T3 tumor to T4. * **Internal Mammary Nodes:** If detected clinically or by imaging, they are staged as **N2b** (if axillary nodes are present) or **N3b** (if axillary nodes are also involved).

Question 1

A 14-week postpartum woman presents with a fluctuant breast swelling. What is the most appropriate initial treatment?

Accepted Answer

Repeated aspirations under antibiotic cover

Answer

Incision and drainage

Answer

Continue breastfeeding with antibiotics

Answer

Analgesics

Question 2

Which of the following is true for triple-negative breast cancer?

Accepted Answer

Aggressive tumor

Answer

Negative for estrogen and progesterone receptors

Answer

Good prognosis with chemotherapy

Answer

Tamoxifen is a chemotherapeutic agent

Question 3

What is true about a modified radical mastectomy?

Accepted Answer

Pectoralis minor is divided

Answer

Pectoralis major is removed

Answer

Axillary lymph nodes are preserved

Answer

Internal mammary lymph nodes are removed

Question 4

In a patient with Ca Breast, ipsilateral supraclavicular lymph nodes are positive. Which of the following represents the stage of malignancy in this patient?

Accepted Answer

Stage III C

Answer

Stage II

Answer

Stage III B

Answer

Stage IV

Question 5

A 56-year-old male patient develops an eccentric hard breast lump over the past few months. A biopsy proves this to be breast carcinoma. What is the approximate incidence of breast cancer in males as a percentage of all breast cancers?

Accepted Answer

Less than 1%

Answer

4%

Answer

7%

Answer

10%

Question 6

What is considered the gold standard flap for breast reconstruction?

Accepted Answer

DIEP flap

Answer

TRAM flap

Answer

LD flap

Answer

Silicone gel implant

Question 7

Which of the following has the best prognosis?

Accepted Answer

<1 cm Size, Node -ve, ER/PR +ve, Her 2 Negative

Answer

<1 cm Size, Node -ve, ER/PR -ve, Her 2 Positive

Answer

<2 cm Size, Node -ve, ER/PR +ve, Her 2 Negative

Answer

<2 cm Size, Node -ve, ER/PR -ve, Her 2 positive

Question 8

What is the most malignant type of carcinoma of the breast?

Accepted Answer

Mastitis carcinomatosa

Answer

Paget's disease

Answer

Anaplastic carcinoma

Answer

Scirrhous carcinoma

Question 9

A 9-week pregnant lady presents with a 2.5 cm mass in the upper outer quadrant of her left breast. Ultrasound did not reveal any abnormality. What is the ideal management?

Accepted Answer

Finger-guided core biopsy

Answer

Aspiration of the cyst and reassurance

Answer

Follow-up one month after delivery

Answer

Mammography

Question 10

Which of the following factors is not included in the TNM staging of carcinoma breast?

Accepted Answer

Nipple retraction

Answer

Satellite nodules

Answer

Inflammation

Answer

Skin ulceration

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?